Search
for
Sort by
Research 31–60 of 1000+
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- Tyrosine kinase inhibition and grey hair
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Skin Pigmentation Types, Causes and Treatment—A Review
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Application of Marine Microbial Natural Products in Cosmetics
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Does Nicastrin Inadequacy Cause Melanocytotoxicity in Human Skin as in the Fish Counterpart?
- INTERACTION OF α-MELANOCYTE-STIMULATING HORMONE, MELATONIN, CYCLIC AMP AND CYCLIC GMP IN THE CONTROL OF MELANOGENESIS IN HAIR FOLLICLE MELANOCYTES IN VITRO
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Antimelanogenic effect of ginsenoside Rg3 through extracellular signal-regulated kinase-mediated inhibition of microphthalmia-associated transcription factor
- 1339 Casein kinase 1 inhibition in keratinocytes enhances the migration of melanocyte precursors in the hair follicle via KitL/c-Kit signaling pathway
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- An overview of management of drug-induced hair and nail disorders
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Skin Biology and Ageing
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The PDGF/PDGFR pathway as a drug target
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Nilontinib induced keratosis pilaris atrophicans
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Rapid hair depigmentation in patient treated with pazopanib
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Gefitinib-induced hair alterations: Figure 1
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature